Substance Use Disorders in Schizophrenia - Clinical Implications of Comorbidity

被引：168
|
作者：
Volkow, Nora D. [1 ]
机构：
[1] NIDA, Off Director, NIH, Bethesda, MD 20892 USA
来源：
SCHIZOPHRENIA BULLETIN | 2009年 / 35卷 / 03期
关键词：
schizophrenia; substance use disorders; comorbidity; NICOTINE DEPENDENCE; ABUSE; DIAGNOSIS; SMOKING; ASSOCIATION; ADDICTION; PSYCHOSIS; ALCOHOL; ILLNESS; PEOPLE;
D O I：
10.1093/schbul/sbp016
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
Nearly half of the people suffering from schizophrenia also present with a lifetime history of substance use disorders (SUD), a rate that is much higher than the one seen among unaffected individuals. This phenomenon suggests that the factors influencing SUD risk in schizophrenia may be more numerous and/or complex than those modulating SUD risk in the general population. It is critically important to address this comorbidity because SUD in schizophrenic patients is associated with poorer clinical outcomes and contributes significantly to their morbidity and mortality.
引用
收藏
页码：469 / 472
页数：4
相关论文
共 50 条
  • [41] Comorbidity of schyzophrenia and disorders due to psychoactive substance use
    Perez Garcia, M.
    Martinez Formoso, S.
    Tajes Alonso, M.
    Paramo Fernandez, M.
    EUROPEAN PSYCHIATRY, 2007, 22 : S124 - S124
  • [42] Effects of age at first substance use and psychiatric comorbidity on the development of substance use disorders
    Sung, MJ
    Erkanli, A
    Angold, A
    Costello, EJ
    DRUG AND ALCOHOL DEPENDENCE, 2004, 75 (03) : 287 - 299
  • [43] Eating disorders and disorders due to substance use comorbidity etiopathogenesis.
    De Frutos Guijarro, J. J.
    Martin Aragon, R.
    Chinchurreta, N.
    Saez Roche, E.
    Calleja Alonso, P.
    Garcia-Consuegra Colado, D.
    Moreno Menguiano, C.
    EUROPEAN PSYCHIATRY, 2020, 63 : S339 - S340
  • [44] Comorbidity of substance use disorders and attention-deficit hyperactivity disorders
    Fallgatter, A. J.
    Jacob, C. P.
    NERVENARZT, 2009, 80 (09): : 1015 - +
  • [45] PERSONALITY DISORDERS AND SUBSTANCE USE DISORDERS COMORBIDITY: FOCUSSING ON PERSONALITY CHARACTERISTICS
    Mateu-Codina, G.
    Diaz-Digon, L.
    Martinez-Riera, R.
    Morro-Fernandez, L.
    Merino-Torres, A.
    Torrens-Melich, M.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [46] PHENOTYPIC AND GENETIC CHARACTERIZATION OF COMORBIDITY BETWEEN SUBSTANCE USE AND SCHIZOPHRENIA
    Hartz, Sarah
    Horton, Amy
    Bierut, Laura
    Pato, Michele
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S135 - S135
  • [47] Schizophrenia and substance use comorbidity: a genome-wide perspective
    Renato Polimanti
    Arpana Agrawal
    Joel Gelernter
    Genome Medicine, 9
  • [48] Schizophrenia and substance use comorbidity: a genome-wide perspective
    Polimanti, Renato
    Agrawal, Arpana
    Gelernter, Joel
    GENOME MEDICINE, 2017, 9
  • [49] Therapeutic management of schizophrenia and substance use disorders dual diagnosis - clinical vignettes
    Vasiliu, Octavian
    ROMANIAN JOURNAL OF MILITARY MEDICINE, 2018, 121 (02) : 26 - 34
  • [50] THE CONTRIBUTION OF SUBSTANCE USE DISORDERS TO MORTALITY IN SCHIZOPHRENIA
    Hjorthoj, Carsten Rygaard
    Ostergaard, M.
    Benros, M. E.
    Toftdahl, N. G.
    Erlangsen, A.
    Andersen, J. T.
    Nordentoft, M.
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S142 - S142
12345